Efficacy of tigecycline versus ceftriaxone plus metronidazole for the treatment of complicated intra-abdominal infections: results from a randomized, controlled trial.

scientific article published on 22 March 2012

Efficacy of tigecycline versus ceftriaxone plus metronidazole for the treatment of complicated intra-abdominal infections: results from a randomized, controlled trial. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1089/SUR.2011.048
P698PubMed publication ID22439781

P50authorNiels QvistQ67928754
P2093author name stringBrian Warren
Ronald Pedersen
Paul C McGovern
Edward T Zito
Tim Babinchak
Heidi Leister-Tebbe
P433issue2
P921main subjectmetronidazoleQ169569
ceftriaxoneQ421713
P304page(s)102-109
P577publication date2012-03-22
P1433published inSurgical InfectionsQ15765824
P1476titleEfficacy of tigecycline versus ceftriaxone plus metronidazole for the treatment of complicated intra-abdominal infections: results from a randomized, controlled trial
P478volume13

Reverse relations

cites work (P2860)
Q60310408A multicenter, double-blind, randomized, comparison study of the efficacy and safety of tigecycline to imipenem/cilastatin to treat complicated intra-abdominal infections in hospitalized subjects in China
Q38255278Bacteriostatic versus bactericidal antibiotics for patients with serious bacterial infections: systematic review and meta-analysis
Q47223062Busting the Myth of "Static vs. Cidal": A Systemic Literature Review
Q35545954Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI).
Q40690093Characteristics and Outcomes of Complicated Intra-abdominal Infections Involving Pseudomonas aeruginosa from a Randomized, Double-Blind, Phase 3 Ceftolozane-Tazobactam Study
Q35782490Clinical characteristics of ceftriaxone plus metronidazole in complicated intra-abdominal infection
Q92341709Cost-effectiveness analysis comparing ceftazidime/avibactam (CAZ-AVI) as empirical treatment comparing to ceftolozane/tazobactam and to meropenem for complicated intra-abdominal infection (cIAI)
Q26797442Efficacy and safety of tigecycline for the treatment of severe infectious diseases: an updated meta-analysis of RCTs
Q47129511Efficacy of intravenous tigecycline in patients with Acinetobacter complex infections: results from 14 Phase III and Phase IV clinical trials
Q21146707Empiric therapy for hospital-acquired, Gram-negative complicated intra-abdominal infection and complicated urinary tract infections: a systematic literature review of current and emerging treatment options
Q41243978Impact of a Dynamic Microbiological Environment on the Clinical Efficacy of Ertapenem and Piperacillin/Tazobactam in the Treatment of Complicated Community-Acquired Intra-Abdominal Infection in Spain: A Cost-Consequence Analysis
Q34057425Multicenter, double-blind, randomized, phase II trial to assess the safety and efficacy of ceftolozane-tazobactam plus metronidazole compared with meropenem in adult patients with complicated intra-abdominal infections.
Q38972381Optimal Treatment for Complicated Intra-abdominal Infections in the Era of Antibiotic Resistance: A Systematic Review and Meta-Analysis of the Efficacy and Safety of Combined Therapy With Metronidazole
Q47095071The efficacy of combined therapy with metronidazole and broad-spectrum antibiotics on postoperative outcomes for pediatric patients with perforated appendicitis

Search more.